genprowebdirectory
Facebook
Linkedin
RSS
Twitter
Youtube
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Search
Facebook
Linkedin
RSS
Twitter
Youtube
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
News
Insights
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
Magazine
Browse Issues
Subscribe
Multimedia
Summits
Webinars
GEN Live
Learning Labs
Podcasts
Resources
A-Lists
eBooks/Perspectives
Tutorials
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Home
2013
Chronic lymphocytic leukemia
Cancer
Genentech Trumpets Phase III Results for CLL Candidate
News
Celgene Halts a Phase III B-Cell CLL Trial Because of Deaths
News
Report: Orphan Drugs Cheaper to Bring to Market, Offer Better ROI
Cancer
Pharmacyclics Achieves Another $50M Milestone
Industry News
Recordati Completes $100M Deal for Rare-Disease Drugs
News
Pfizer Raises Its Bet on Nodality
Cancer
Five Is Lucky Number for Pharmacyclics
Cancer
Infinity Regains Rights to PI3K and FAAH Programs
Insights
Gene Therapy Briefs
Cancer
TG Therapeutics Licenses mAb-Based Drug to LFB Biotechnologies
1
2
3
4
...
8
Page 3 of 8
Scroll Up